TATETSU HIRO 立津央

… Alternative Names

Tatetsu Hiro 立津央

TATETSU Hiro 立津央

Less

Researcher Number	00433029
Other IDs	https://orcid.org/0000-0001-8131-3401
Affiliation (Current)	2025: 熊本大学, 病院, 講師
Affiliation (based on the past Project Information) *help	2019 – 2024: 熊本大学, 病院, 講師 2018: 熊本大学, 大学院生命科学研究部(医), 助教 2017: 熊本大学, 医学部附属病院, 助教 2009: Kumamoto University, 医学部附属病院, 医員 2008: Kumamoto University, 医学部・附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Hematology
Keywords	Principal Investigator SALL4 / 骨髄異形成症候群 / PU.1 / DLBCL / MDS / 予後 / IRF4 / 多発性骨髄腫 / 血液腫瘍学

Analysis of downregulation of PU.1 expression in diffuse large B-cell lymphoma (DLBCL)Principal Investigator
- Principal Investigator
  
  立津央
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kumamoto University
骨髄異形成症候群に対する治療標的としてのSALL4の機能的解析Principal Investigator
- Principal Investigator
  
  立津央
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kumamoto University
The role of SALL4 in myelodysplastic syndromePrincipal Investigator
- Principal Investigator
  
  Tatetsu Hiro
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Kumamoto University
Stratification of multiple myeloma according to PU.1 expression levelPrincipal Investigator
- Principal Investigator
  
  TATETSU Hiro
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Kumamoto University

All 2024 2023 2022 2021 2020 2009

All Journal Article Presentation

[Journal Article] Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT2024
- Author(s)
  Nakamura Takahisa、Tatetsu Hiro、Higuchi Yusuke、Endo Shinya、Shiraishi Shinya、Kawanaka Koichi、Imakane Daisuke、Sonoda Miyu、Furuta Rie、Shichijo Takafumi、Honda Yumi、Karube Kennosuke、Mikami Yoshiki、Nosaka Kisato、Matsuoka Masao、Yasunaga Jun-ichirou
- Journal Title
  
  Journal of Clinical and Experimental Hematopathology
  
  Volume: 64 Issue: 1 Pages: 45-51
- DOI
  10.3960/jslrt.23046
- ISSN
  1346-4280, 1880-9952
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08420
[Journal Article] Robust prognostic value of histologic transformation in patients with early progression of follicular lymphoma2023
- Author(s)
  Shichijo Takafumi、Tatetsu Hiro、Nosaka Kisato、Higuchi Yusuke、Kikukawa Yoshitaka、Toyoda Kosuke、Shiraishi Shinya、Yasunaga Jun-ichirou、Matsuoka Masao
- Journal Title
  
  Leukemia & Lymphoma
  
  Volume: 64 Issue: 10 Pages: 1706-1710
- DOI
  10.1080/10428194.2023.2226429
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-23K15303, KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-20H03514
[Journal Article] Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma2023
- Author(s)
  Tatetsu Hiro、Higuchi Yusuke、Shichijo Takafumi、Oda Kazutaka、Nakata Hirotomo、Yasunaga Jun-ichirou、Nosaka Kisato、Matsuoka Masao
- Journal Title
  
  International Journal of Hematology
  
  Volume: 118 Issue: 2 Pages: 303-305
- DOI
  10.1007/s12185-023-03629-4
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-23K15303, KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-20H03514
[Journal Article] Waldenstrom's macroglobulinemia-like B cell lymphoma with MYD88 L265P mutation and t(14;18)(q32;q21) involving IGH-MALT12023
- Author(s)
  Furuta Rie、Tatetsu Hiro、Yasunaga Jun-ichirou、Ueno Mitsunori、Oshiro Kento、Kumanomido Satoshi、Kawano Yawara、Higuchi Yusuke、Honda Yumi、Mikami Yoshiki、Nosaka Kisato、Matsuoka Masao
- Journal Title
  
  Leukemia Research Reports
  
  Volume: 20 Pages: 100389-100389
- DOI
  10.1016/j.lrr.2023.100389
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-20H03514
[Journal Article] Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome2023
- Author(s)
  Tatetsu Hiro、Watanabe Miho、Liu Jun、Tokunaga Kenji、Iwanaga Eisaku、Komohara Yoshihiro、Thrash Emily、Bassal Mahmoud A.、Matsuoka Masao、Tenen Daniel G.、Chai Li
- Journal Title
  
  Clinical and Translational Medicine
  
  Volume: 13 Issue: 8
- DOI
  10.1002/ctm2.1327
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08420
[Journal Article] Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy2023
- Author(s)
  Hirano Taichi、Tatetsu Hiro、Ueno Shikiko、Shichijo Takafumi、Furukawa Shota、Tsujihashi Mizuho、Miyakawa Toshikazu、Shiraishi Shinya、Higuchi Yusuke、Uchiba Mitsuhiro、Yasunaga Jun-ichirou、Nosaka Kisato、Matsuoka Masao
- Journal Title
  
  Journal of Clinical and Experimental Hematopathology
  
  Volume: 63 Issue: 4 Pages: 266-269
- DOI
  10.3960/jslrt.23033
- ISSN
  1346-4280, 1880-9952
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-23K15303, KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-20H03514
[Journal Article] Beneficial impact of first‐line mogamulizumab‐containing chemotherapy in adult T‐cell leukaemia‐lymphoma2022
- Author(s)
  Shichijo Takafumi、Nosaka Kisato、Tatetsu Hiro、Higuchi Yusuke、Endo Shinya、Inoue Yoshitaka、Toyoda Kosuke、Kikukawa Yoshitaka、Kawakita Toshiro、Yasunaga Jun‐ichirou、Matsuoka Masao
- Journal Title
  
  British Journal of Haematology
  
  Volume: 198 Issue: 6 Pages: 983-987
- DOI
  10.1111/bjh.18281
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-19H03689, KAKENHI-PROJECT-20H03514
[Journal Article] Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma2022
- Author(s)
  Shichijo Takafumi、Tatetsu Hiro、Nosaka Kisato、Higuchi Yusuke、Kikukawa Yoshitaka、Inoue Yoshitaka、Toyoda Kosuke、Yasunaga Jun‐ichirou、Matsuoka Masao
- Journal Title
  
  eJHaem
  
  Volume: - Issue: 2 Pages: 385-393
- DOI
  10.1002/jha2.393
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K22904, KAKENHI-PROJECT-21K08420, KAKENHI-PROJECT-22K16325, KAKENHI-PROJECT-19H03689, KAKENHI-PROJECT-20H03514
[Journal Article] The Interplay between Transcription Factor SALL4 and Histone Modifiers in Hematopoietic Stem and Progenitor Cells2021
- Author(s)
  Hiro Tatetsu
- Journal Title
  
  Journal of Cellular Immunology
  
  Volume: 3 Issue: 1 Pages: 26-30
- DOI
  10.33696/immunology.3.073
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09930
[Journal Article] Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor2009
- Author(s)
  Tatetsu H
- Journal Title
  
  Leukemia Research 33
  
  Pages: 197-200
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20790677
[Journal Article] PU. 1 induces apoptosis in myeloma cells through direct transactivation of TRAIL2009
- Author(s)
  Ueno S, Tatetsu H, Hata H, Iino T, Niiro H, Akashi K, Tenen DG, Mitsuya H, Okuno Y
- Journal Title
  
  Oncogene 28(46)
  
  Pages: 4116-25
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20790677
[Presentation] Impact of sensitivity to 2nd and 3rd line therapy in refractory/relapsed large B-cell lymphoma.2023
- Author(s)
  立津央
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K08420
[Presentation] Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukemia-lymphoma (ATL)2022
- Author(s)
  Hiro Tatetsu
- Organizer
  International Conference on Human Retrovirology: HTLV 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08420
[Presentation] Predictive impact of soluble interleukin-2 receptor and number of extranodal sites to identify the patients at very high risk of CNS relapse in diffuse large B-cell lymphoma2022
- Author(s)
  Hiro Tatetsu
- Organizer
  第62回日本リンパ網内系学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-21K08420
[Presentation] Oncofetal protein SALL4 is highly expressed in myelodysplastic syndrome alongside with NAT10 and P532020
- Author(s)
  Hiro Tatetsu
- Organizer
  American Society of Hematology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09930

1. OKUNO Yutaka (80363539)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. HATA Hiroyuki (70271129)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. UENO Shikiko (40571047)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 樋口悠介

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

TATETSU HIRO 立津 央

Tatetsu Hiro 立津 央

TATETSU Hiro 立津 央

Research Projects

Research Products

Co-Researchers

Analysis of downregulation of PU.1 expression in diffuse large B-cell lymphoma (DLBCL)Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

骨髄異形成症候群に対する治療標的としてのSALL4の機能的解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The role of SALL4 in myelodysplastic syndromePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Stratification of multiple myeloma according to PU.1 expression levelPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT2024

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Robust prognostic value of histologic transformation in patients with early progression of follicular lymphoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Waldenstrom's macroglobulinemia-like B cell lymphoma with MYD88 L265P mutation and t(14;18)(q32;q21) involving IGH-MALT12023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy2023

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Beneficial impact of first‐line mogamulizumab‐containing chemotherapy in adult T‐cell leukaemia‐lymphoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Interplay between Transcription Factor SALL4 and Histone Modifiers in Hematopoietic Stem and Progenitor Cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor2009

TATETSU HIRO 立津央

Tatetsu Hiro 立津央

TATETSU Hiro 立津央